These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7966873)

  • 1. Management of heart failure. IV. Anticoagulation for patients with heart failure due to left ventricular systolic dysfunction.
    Baker DW; Wright RF
    JAMA; 1994 Nov 23-30; 272(20):1614-8. PubMed ID: 7966873
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacological prevention of thromboembolism in patients with left ventricular dysfunction.
    Thatai D; Ahooja V; Pullicino PM
    Am J Cardiovasc Drugs; 2006; 6(1):41-9. PubMed ID: 16489847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antithrombotics in heart failure with reduced ejection fraction and normal sinus rhythm: an evidence appraisal.
    Prom R; Usedom JE; Dull RB
    Ann Pharmacother; 2014 Feb; 48(2):226-37. PubMed ID: 24259641
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Wrigley BJ; Pisters R
    Cochrane Database Syst Rev; 2012 Jun; (6):CD003336. PubMed ID: 22696335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticoagulation versus placebo for heart failure in sinus rhythm.
    Lip GY; Shantsila E
    Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD003336. PubMed ID: 24683002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thromboembolism in heart failure: who should be treated?
    Diet F; Erdmann E
    Eur J Heart Fail; 2000 Dec; 2(4):355-63. PubMed ID: 11113711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):461-8. PubMed ID: 12096151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anticoagulation for heart failure in sinus rhythm.
    Lip GY; Gibbs CR
    Cochrane Database Syst Rev; 2001; (4):CD003336. PubMed ID: 11687190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Anticoagulant therapy in patients with dilated cardiomyopathy].
    Gensini GF; Rostagno C
    Ann Ital Med Int; 1998; 13(4):227-32. PubMed ID: 10349204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Anticoagulation in primary prevention of thromboembolism in advanced left ventricular dysfunction].
    Siaplaouras S; Heisel A; Buob A; Jung J
    Med Klin (Munich); 2001 May; 96(5):281-6. PubMed ID: 11395992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anticoagulation in patients with left ventricular systolic dysfunction and sinus rhythm: when?
    Sivri N; Yetkin E; Tekin GO; Yalta K; Waltenberger J
    Clin Appl Thromb Hemost; 2014 Oct; 20(7):729-34. PubMed ID: 23615290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiplatelet agents versus control or anticoagulation for heart failure in sinus rhythm.
    Lip GY; Gibbs CR
    Cochrane Database Syst Rev; 2001; (4):CD003333. PubMed ID: 11687189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thromboembolism and antithrombotic therapy for heart failure in sinus rhythm: an executive summary of a joint consensus document from the ESC Heart Failure Association and the ESC Working Group on Thrombosis.
    Lip GY; Piotrponikowski P; Andreotti F; Anker SD; Filippatos G; Homma S; Morais J; Pullicino P; Rasmussen LH; Marín F; Lane DA;
    Thromb Haemost; 2012 Dec; 108(6):1009-22. PubMed ID: 23093044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticoagulation in chronic heart failure and left ventricular dysfunction].
    Wichter T; Breithardt G
    Dtsch Med Wochenschr; 2002 Oct; 127(41):2145-8. PubMed ID: 12397561
    [No Abstract]   [Full Text] [Related]  

  • 15. Antiplatelet and anticoagulant therapy in the prevention of thromboemboli in chronic heart failure.
    Garg RK; Gheorghiade M; Jafri SM
    Prog Cardiovasc Dis; 1998; 41(3):225-36. PubMed ID: 9872608
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thromboembolic complications in patients with newly diagnosed dilated cardiomyopathy immediately after initiation of congestive heart failure treatment: just a coincidence or should we pay more attention?
    Yetkin E; Topal E; Yanik A; Ozten M
    Clin Appl Thromb Hemost; 2010 Aug; 16(4):480-2. PubMed ID: 19520683
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic thromboembolism in chronic heart failure. A prospective study in 406 patients.
    Cioffi G; Pozzoli M; Forni G; Franchini M; Opasich C; Cobelli F; Tavazzi L
    Eur Heart J; 1996 Sep; 17(9):1381-9. PubMed ID: 8880024
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dilated cardiomyopathy and role of antithrombotic therapy.
    Abdo AS; Kemp R; Barham J; Geraci SA
    Am J Med Sci; 2010 Jun; 339(6):557-60. PubMed ID: 20186041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombosis and embolism from cardiac chambers and infected valves.
    Adams PC; Cohen M; Chesebro JH; Fuster V
    J Am Coll Cardiol; 1986 Dec; 8(6 Suppl B):76B-87B. PubMed ID: 3537072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulation in patients with dilated cardiomyopathy and sinus rhythm: a critical literature review.
    Sirajuddin RA; Miller AB; Geraci SA
    J Card Fail; 2002 Feb; 8(1):48-53. PubMed ID: 11862583
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.